Cision PR Newswire

RiboX Therapeutics Announces FDA IND Clearance for RXIM002, the first Circular RNA-Based in vivo CAR Therapy for Autoimmune Cytopenias

The FDA IND clearance supports the initiation of RiboX's Phase 1 clinical trial evaluating targeted LNP-delivered circular RNA-based in vivo CAR-T therapy for autoimmune cytopenias. RXIM002 represents the world's first circular RNA-based in vivo CAR-T therapy achieving FDA IND clearance. RiboX expands its clinical-stage pipeline through its proprietary...

Change in the number of shares and votes in AB Electrolux

STOCKHOLM, July 1, 2026 /PRNewswire/ -- AB Electrolux has, as previously announced, carried out a rights issue of shares of Class A and Class B,...

Zenerate Announces Partnership with AvalonBay Communities to Support Early-Stage Multifamily Feasibility Analysis

LOS ANGELES, June 30, 2026 /PRNewswire/ -- Zenerate, an AI-powered real estate feasibility platform, is pleased to announce a new partnership with AvalonBay Communities, Inc.,...

RARE WWII LUFTWAFFE AIRCRAFT TO SELL IN GLOBAL OFFERING OF PRIVATE COLLECTORS LIQUIDATION

SALE INCLUDES STORIED GERMAN MESSERSCHMITT 109, E1 -WHICH DOCUMENTS DOWNED BRITISH RAF SPITFIRE AS "FIRST KILL" -AUGUST 10TH 1940 AND ANOTHER OVER ENGLAND, SEPTEMBER...

GreenTree Hospitality Group Ltd. Reports First Quarter of 2026 Financial Results

Total revenues decreased by 14.0% year over year to RMB227.7 million (US$33.0 million). Income from operations was RMB28.7 million...